Awareness of and adherence to cancer screening guidelines among health professionals in Japan

Cancer Science

Volumn 98, Issue 8, 2007, Pages 1241-1247

  Hamashima, Chisato ^a   Saito, Hiroshi ^a   Sobue, Tomotaka ^b  

^a Research Center for Cancer Prevention and Screening   (Japan)

^b Center for Cancer Control and Information Services   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANCER SCREENING; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; EVIDENCE BASED PRACTICE; FEMALE; GOVERNMENT; HEALTH BEHAVIOR; HEALTH PRACTITIONER; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POSTAL MAIL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH OCCUPATIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PRACTICE GUIDELINES; QUESTIONNAIRES;

EID: 34347222930     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00512.x     Document Type: Article

References (36)

1. Hisamichi S, Tsuji I, Tsubono Y, Nishino Z. In: Hisamichi S, ed. Guidelines For Cancer Screening Programs. Tokyo: Japan Public Health Association, 2001: 1-16. (In Japanese)
2. Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer 2004; 101: 1201-13.
3. Department of Health Statistics and Information Ministry of Health and Welfare. National Survey on Cancer Screening 2006. Tokyo: Society of Public Health Statistics 2006. (In Japanese.)
4. Hinohara S. 2005 annual report of accredited Ningen Dock Institute in Japan. Official J Jpn Soc Ningen Dock 2006; 21: 102-19. (In Japanese)
5. Briss P, Rimer B, Coates RC et al. Promoting informed decisions about cancer screening in communities and health care systems. Am J Prev Med 2004; 26: 67-80.
6. Shreidan SL, Hariss RP, Woolf SH. Shared decision making about screening and chemoprevention: A suggested approach from the US Preventive Services Task Force. Am J Prev Med 2004; 26: 56-66.
7. Gilbert A, Kanarek N. Colorectal cancer screening: Physician recommendation is influential advice to Marylanders. Prev Med 2005; 41: 367-79.
8. Lewis SF, Jensen NM. Screening sigmoidoscopy. J General Int Med 1996; 11: 542-4.
9. Taplin SH, Urban N, Taylor VM et al. Conflicting national recommendations and the use of screening mammography: Does the physician's recommendation matter? Am Board Pract 1997; 10: 88-95.
10. Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedule mammography rescreening in the national breast and cervical cancer early detection program. Cancer Epidemol Biomakers Prev 2004; 13: 620-30.
11. Sharma VK, Vasudeva R, Howden CW. Colorectal cancer screening and surveillance practices by primary care physicians: Results of a national survey Am J Gastroenterol 2000; 95: 1551-6.
12. Sharma VK, Corder FA, Raufman JP et al. Survey of internal medicine residents'use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol 2000; 95: 2068-73.
13. Sharma VK, Corder FA, Fancher J, Howden CW. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol 2000; 95: 3629-32.
14. Mosca L, Linfant AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499-510.
15. Young JM, Ward JE. Strategies to improve cancer screening in general practice: Are guidelines the answer? Fam Prac 1999; 16: 66-70.
16. Holland-Barkis P, Forjuoh SN, Couchman GR, Capen C, Rascoe TG, Reis MD. Primary care physician awareness and adherence to cervical cancer guidelines in Texas. Prev Med 2006; 342: 140-5.
17. US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd edn. Batimore: Williams & Wilkins, 1996.
18. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004; 291: 71-8.
19. Sirovich BE, Schwartz LM, Woolshin S et al. Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence? JAMA 2003; 289: 1414-20.
20. Czaja R, McFall SL, Warnecke RB et al. Preference of community physicians for cancer screening guidelines. Ann Intern Med 1994; 120: 602-8.
21. Voss JD, Schectman JM. Prostate cancer practices and beliefs: A longitudinal physician survey. J Gen Intern Med 2001; 16: 831-7.
22. Sobue T, Hamashima C, Saito H, Shimada G, Matusda K, Nishida H. Guideline for colorectal cancer screening. Jpn J Cancer Chemother 2005; 32: 901-15. (In Japanese.)
23. Fukao A, Hamashima C, Saito H et al. Guideline for gastric cancer screening. Jpn J Cancer Chemother 2006; 33: 1183-98. (In Japanese)
24. Zapka JG, Puelo E, Taplin S et al. Breast and cervical cancer screening: clinicians'views on health plan guidelines and implementation efforts. J Natl Cancer Monographs 2005; 35: 46-54.
25. Seeff LC, Nadel MR, Kalubunde CN et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer 2004; 100: 2093-103.
26. Volk RJ, Cass AR, Sann SJ. A randomized controlled trial of shared decision making. Arch Fam Med 1999; 8: 333-40.
27. Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med 1996; 11: 342-9.
28. Wolf AM, Nasser JF, Wolf AM. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996; 156: 307-24.
29. Davison BJ, Krik P, Degner LF, Hassard TH. Information and patient perception in screening for prostate cancer. Patient Edu Coun 1999; 37: 255-63.
30. Schapira MM, VanRuiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening test. J Fam Pract 2000; 49: 418-24.
31. Frosch DL, Kaplan RM, Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med 2001; 16: 391-8.
32. Mandelblatt JS, Yabroff KR. Effectiveness of intervenes designed to increase mammography use: A meta-analysis of provider-targeted strategies. Cancer Epidemiol Biomarker Prev 1999; 8: 759-67.
33. Gray M. Canadian clinician and patients need clean, clear knowledge. CMAJ 2006; 175: 129.
34. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
35. Zitzelsberger L, Grunfeld E, Graham ID. Family physicians'perspectives on practice guidelines related to cancer control. BMC Fam Prac 2004; 5: 25.
36. Department of Health Statistics and Information Ministry of Health and Welfare. National Lifestyle Survey 2001, vol 2. Tokyo: Society of Public Health Statistics, 2002.